(UPDATED) In stable CAD patients, using intravascular lithotripsy to break up superficial or deep calcium and pave the way for stent implantation results in good outcomes to 1 year, with low rates of ...
(UPDATED) Coronary intravascular lithotripsy shows promise for improving the ability to optimize PCI in severely calcified lesions, with good safety and efficacy out to 30 days, according to data from ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — An intravascular lithotripsy device used for vessel preparation for stenting in patients with ...
Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for ...
Abbott announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Bryn Mawr Hospital is the first hospital in Pennsylvania to enroll a patient in a clinical trial on a new treatment for people with an advanced form of heart disease. The treatment, Intravascular ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that aims to fracture hardened calcium within the ...
SANTA CLARA, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results